The Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
CONTEXT: The polycystic ovary syndrome (PCOS) is the commonest endocrine abnormality in women of reproductive age. OBJECTIVE: To determine the rate of hospital admissions for women with PCOS in Western Australian population in comparison to women without PCOS. DESIGN: A population-based retrospective cohort study using data linkage in a statewide hospital morbidity database system. SETTING: All hospitals within Western Australia. PARTICIPANTS: A total of 2566 women with PCOS hospitalized from 1997-2011 and 25 660 randomly selected age-matched women without a PCOS diagnosis derived from the electoral roll. MAIN OUTCOME MEASURES: Hospitalizations by ICD-10-M diagnoses from 15 years were compared. RESULTS: Hospitalizations were followed until a median age of 35.8 years (interquartile range, 31.0-39.9). PCOS was associated with more nonobstetric and non-injury-related hospital admissions (median, 5 vs 2; P < .001), a diagnosis of adult-onset diabetes (12.5 vs 3.8%), obesity (16.0 vs 3.7%), hypertensive disorder (3.8 vs 0.7%), ischemic heart disease (0.8 vs 0.2%), cerebrovascular disease (0.6 vs 0.2%), arterial and venous disease (0.5 vs 0.2% and 10.4 vs 5.6%, respectively), asthma (10.6 vs 4.5%), stress/anxiety (14.0 vs 5.9%), depression (9.8 vs 4.3%), licit/illicit drug-related admissions (8.8 vs 4.5%), self-harm (7.2 vs 2.9%), land transport accidents (5.2 vs 3.8%), and mortality (0.7 vs 0.4%) (all P < .001). Women with PCOS had a higher rate of admissions for menorrhagia (14.1 vs 3.6%), treatment of infertility (40.9 vs 4.6%), and miscarriage (11.1 vs 6.1%) and were more likely to require in vitro fertilization (17.2 vs 2.0%). CONCLUSION: PCOS has profound medical implications for the health of women, and health care resources should be directed accordingly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prevalence of malignant cancer has been reported to be 2-fold greater or not different in those with PCOS.6,32”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [6]
In the citing paper
“The prevalence of endometrial cancer has been reported to be increased 3-5 fold in those with PCOS in the postmenopause years, and an increased risk for ovarian cancer has been reported in younger women with PCOS in the premenopause years.6,123, 124, 125”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [6]
In the citing paper
“Higher rates of endometriosis among women with PCOS (up to 70%) have been reported among women hospitalized for PCOS34 or with self-reported infertility and/or pelvic pain,21”
From Examining the co-occurrence of endometriosis and polycystic ovarian syndrome (2023) · cites this paper as [34]
In the citing paper
“Our data showed that mental health and psychiatric disorders had a 30% higher prevalence in those with PCOS, consistent with findings of previous population cohort studies.6,29,31,32,126,127”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [6]
In the citing paper
“The diagnosis of PCOS included the ICD-9 and ICD-10 codes, and these have been validated and used in previous epidemiologic studies.6,10,17,27,32,55, 56, 57”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [6]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976 · cited 6×
“experience a lower quality of life (2, 41, 42) and are prone”
BackgroundResultInfluentialLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919 · cited 2×
“tional Health and Medical Research Council (3), and in the United States by The Endocrine Society statement (4).”
BackgroundLegro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108 · cited 1×
“Our finding of a four times greater prevalence of type II diabetes among women with PCOS admitted to hospital is in agreement with the literature (2, 37).”
ResultHolman, C. D. J., Bass, A. J., Rouse, I. L., & Hobbs, M. S. T. (1999) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.1999.tb01297.x · Cited by 1,037 · cited 1×
“org/data-linkage/ data-collections) within the linked data from the WA Data-Linkage System that has been validated previously and used extensively for health research (26).”
MethodWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747 · cited 2×
“This data linkage study cannot determine causality, only associations; however, insulin resistance is more prevalent in women with PCOS and may occur in up to 75% of lean women with PCOS (34), and it is believed that insulin resistance is integral to the underlying pathophysiology of the cardiometabolic perturbation i…”
Background
Cited by
Items 101–200 of 390
Anagnostis, P. G., Paparodis, R. D., Bosdou, J. Κ., Bothou, C., Μacut, D., Goulis, D. G., & Livadas, S. (2021) · Endocrine · doi:10.1007/s12020-021-02801-2 · Cited by 52
Evolutionary origins of polycystic ovary syndrome: An environmental mismatch disorder
Charifson, M. A., & Trumble, B. C. (2019) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eoz011 · Cited by 44
“An estimated 30–70% of females with PCOS are also obese across a cohort of industrialized countries and a meta-analysis of females with PCOS showed that they are estimated to have a 2-fold increased incidence of impaired glucose tolerance and T2DM [1, 24].”
BackgroundInfluentialPolycystic Ovary Syndrome in Adolescence
Deans, R. (2019) · Medical Sciences · doi:10.3390/medsci7100101 · Cited by 72
“Depression and anxiety symptoms are more common in PCOS women compared with BMI matched subjects [41,42] although these data are not focused on an adolescent population.”
BackgroundCardiometabolic Risk in Polycystic Ovary Syndrome
Cooney, L. G., & Dokras, A. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.11.001 · Cited by 44
“Population-based studies also have shown higher rates of DM in women with PCOS, some of which also adjusted for BMI.(22,23) A large cross-sectional study found higher rates of insulin resistance in the HA PCOS phenotypes but no difference in rates of hyperglycemia in PCOS phenotypes.”
BackgroundResultInfluentialGut microbiota in adolescent girls with polycystic ovary syndrome: Effects of randomized treatments
García-Beltrán, C., Malpique, R., Carbonetto, B., González‐Torres, P., Henares, D., Brotons, P., Muñoz‐Almagro, C., López‐Bermejo, A., de Zegher, F., & Ibáñez, L. (2020) · Pediatric Obesity · doi:10.1111/ijpo.12734 · Cited by 49
“The syndrome often associates with comorbidities in adulthood, including subfertility, type 2 diabetes and increased cardiovascular disease risk, among others.(4,5) We have recently shown that in girls with PCOS, a low-dose combination of one mixed anti-androgen and antimineralocorticoid (spironolactone), and two insu…”
BackgroundQuality of life and sexual function in women with polycystic ovary syndrome: a comprehensive review
Castelo‐Branco, C., & Naumova, I. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1670788 · Cited by 54
“2015 [37] N1⁄4 2566 (PCOS) N1⁄4 25660 (CG)) Hospitalizations by ICD-10-M diagnoses Stress/anxiety 14.”
Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome
Feldman, R., O’Neill, K. E., Butts, S. F., & Dokras, A. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.009 · Cited by 46
Rashad, N. M., El‐Shal, A. S., Amin, A. I., & Soliman, M. H. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.06.029 · Cited by 45
Ryu, K.-J., Kim, M. S., Kim, H. K., Kim, Y. J., Yi, K. W., Shin, J., Hur, J. Y., Kim, T., & Park, H. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.12.018 · Cited by 49
Rani, R., Hajam, Y. A., Kumar, R., Bhat, R. A., Rai, S., & Rather, M. A. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100161 · Cited by 50
Kujanpää, L., Arffman, R. K., Pesonen, P., Korhonen, E., Karjula, S., Järvelin, M., Franks, S., Tapanainen, J. S., Morin‐Papunen, L., & Piltonen, T. T. (2022) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.14382 · Cited by 40
Androgens regulate scarless repair of the endometrial “wound” in a mouse model of menstruation
Cousins, F. L., Kirkwood, P. M., Murray, A. A., Collins, F., Gibson, D. A., & Saunders, P. T. K. (2016) · The FASEB Journal · doi:10.1096/fj.201600078r · Cited by 39
“In women with polycystic ovarian syndrome, the ovaries typically produce excess androgens, and some womenwith polycystic ovarian syndrome report heavy or extended bleeding duringmenses that would be consistent with an association between unusually high levels of circulating androgens and aberrant endometrial repair (1…”
BackgroundPililis, S., Lampsas, S., Kountouri, A., Pliouta, L., Korakas, E., Livadas, S., Thymis, J., Peppa, Μ., Kalantaridou, S., Oikonomou, E. K., et al. (2024) · Medicina · doi:10.3390/medicina60101656 · Cited by 64
“…disease, ischemic heart disease, and arterial/venous disease of 2.58 (1.43–4.67), 2. hazard ratios (HRs) for cerebrovascular disease, ischemic heart disease, and arterial/venous disease of 2.58 (1.43–4.67), 2.89 (1.68–4.97), and 1.81 (1.59–2.05), respectively, compared to controls [23].”
InfluentialPolycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies
Jacewicz‐Święcka, M., & Kowalska, I. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3054 · Cited by 38
“2%.(86) Additionally, Merz et al observed a trend toward more prevalent multivessel CHD in postmenopausal women with PCOS (P = .”
BackgroundInfluentialCai, H., Mol, B. W., Gordts, S., Wang, H., Wang, T., Li, N., & Shi, J. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16590 · Cited by 40
Teede, H. J., Moran, L., Morman, R., Gibson‐Helm, M. E., Dokras, A., Berry, L., Laven, J. S. E., Joham, A. E., Piltonen, T., Costello, M., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103287 · Cited by 50
Polycystic ovary syndrome, personality, and depression: A twin study
Cesta, C. E., Kuja‐Halkola, R., Lehto, K., Iliadou, A. N., & Landén, M. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.08.007 · Cited by 38
Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity
Htet, T. D., Teede, H. J., de Courten, B., Loxton, D., Real, F. G., Moran, L. J., & Joham, A. E. (2017) · European Respiratory Journal · doi:10.1183/13993003.01334-2016 · Cited by 34
Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease
Dubey, P., Reddy, S., Sharma, K., Johnson, S., Hardy, G., & Dwivedi, A. K. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02050-5 · Cited by 52
“A retrospective cohort study using data linkage of younger women (median age at follow-up 35.8 years) hospitalized in Australia found a higher risk of ischemic heart disease (hazard ratio (HR) 2.89; 95% CI, 1.68–4.97; p < 0.001) and cerebrovascular disease in PCOS women [28].”
InfluentialThe Involvement of Granulosa Cells in the Regulation by Gonadotropins of Cyp17a1 in Theca Cells
Kakuta, H., Iguchi, T., & Sato, T. (2018) · In Vivo · doi:10.21873/invivo.11391 · Cited by 40
Fernandez, E. D. T., Huffman, A. M., Syed, M., Romero, D. G., & Cardozo, L. L. Y. (2019) · Endocrinology · doi:10.1210/en.2019-00450 · Cited by 37
Polycystic ovary syndrome and postpartum depression symptoms: a population-based cohort study
Koric, A., Singh, B., VanDerslice, J. A., Stanford, J. B., Rogers, C. R., Egan, D., Agyemang, D. O., & Schliep, K. C. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.12.1215 · Cited by 36
“Similarly, PPD effect variables were created for those who had (3) both postpartum depressed mood and anhedonia and (4) either postpartum depressed mood or anhedonia.”
BackgroundIs There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?
Carmina, E., & Lobo, R. A. (2018) · Journal of Women s Health · doi:10.1089/jwh.2018.7162 · Cited by 41
“21 The women had a median age of 27.9 years and were followed until a median age of 35.8 years.”
InfluentialWang, B., Hao, M., Yang, Q., Li, J., & Guo, Y. (2016) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-016-0704-6 · Cited by 38
The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
Dawson, A. J., Sathyapalan, T., Vince, R., Coady, A.-M., Ajjan, R. A., Kilpatrick, E. S., & Atkin, S. L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00189 · Cited by 33
Risk of cardiovascular disease in women and men with subfertility: the Trøndelag Health Study
Skåra, K. H., Åsvold, B. O., Hernáez, Á., Fraser, A., Rich-Edwards, J. W., Farland, L. V., Næss, Ø., Lawlor, D. A., Brumpton, B. M., & Magnus, M. C. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.05.038 · Cited by 30
Involvement of Luteinizing Hormone in Alzheimer Disease Development in Elderly Women
Rao, C. V. (2017) · Reproductive Sciences · doi:10.1177/1933719116658705 · Cited by 34
Díaz, M., Bassols, J., López‐Bermejo, A., de Zegher, F., & Ibáñez, L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz204 · Cited by 34
Quercetin and polycystic ovary syndrome
Ma, C., Xiang, Q., Song, G., & Wang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1006678 · Cited by 43
“, 2015), significantly increase the hospitalization rate of women and bring a great economic burden to patients, families and society (Hart and Doherty, 2015).”
BackgroundShorakae, S., Abell, S. K., Hiam, D., Lambert, É., Eikelis, N., Jona, E., Sari, C. I., Stepto, N. K., Lambert, G. W., de Courten, B. V., et al. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.11.020 · Cited by 29
Gholinezhad, M., Gholsorkhtabaramiri, M., Esmaeilzadeh, S., & Ghanbarpour, A. (2018) · PubMed Central · doi:10.22088/cjim.9.3.260 · Cited by 40
“On the other hand, greater prevalence of metabolic abnormalities is seen in the presence of obesity alongside PCOs phenotype (10-12).”
BackgroundIntegrated Model of Care for Polycystic Ovary Syndrome
Tay, C., Moran, L., Wijeyaratne, C., Redman, L., Norman, R., Teede, H., & Joham, A. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1667310 · Cited by 29
Palomba, S., Santagni, S., Gibbins, K. J., Sala, G. B. L., & Silver, R. M. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.08.007 · Cited by 35
Decreased levels of sRAGE in follicular fluid from patients with PCOS
Wang, B., Li, J., Yang, Q., Zhang, F., Hao, M., & Guo, Y. (2016) · Reproduction · doi:10.1530/rep-16-0359 · Cited by 30
Li, Y., Wang, L., Xu, J., Niu, W., Shi, H., Hu, L., Zhang, Y., Zhang, M., Bao, X., Zhang, N., et al. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.01.026 · Cited by 28
Bozdağ, G., Mümüşoğlu, S., Çoşkun, Z. Y., Yaralí, H., & Yıldız, B. O. (2019) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2019.04.002 · Cited by 32
Glintborg, D., & Andersen, M. (2017) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000410 · Cited by 28
Li, L., Zhang, J., Deng, Q., Li, J., Li, Z., Xiao, Y., Hu, S., Li, T., Tan, Q., Li, X., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164538 · Cited by 30
Association between obesity in women with polycystic ovary syndrome and adverse obstetric outcomes
Peeva, M., Badeghiesh, A. M., Baghlaf, H. A., & Dahan, M. H. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.02.007 · Cited by 26
Recent advances of nanotechnology in the treatment and diagnosis of polycystic ovary syndrome
Javid‐Naderi, M. J., Mahmoudi, A. A., Kesharwani, P., Jamialahmadi, T., & Sahebkar, A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104014 · Cited by 34
Specific Alteration of Branched-Chain Amino Acid Profile in Polycystic Ovary Syndrome
Paczkowska, K., Rachoń, D., Berg, A., Rybka, J., Kapczyńska, K., Bolanowski, M., & Daroszewski, J. (2023) · Biomedicines · doi:10.3390/biomedicines11010108 · Cited by 26
“Women with PCOS have an increased risk of insulin resistance (IR), type 2 diabetes, obesity and cardiovascular disease [3] and they are predisposed to develop metabolic syndrome with a rate of progression as high as 50% [6].”
BackgroundMitochondrial function in women with polycystic ovary syndrome
Cozzolino, M., & Seli, E. U. (2020) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000619 · Cited by 24
“Women with PCOS require assisted reproductive technology (ART) 8–10 times more frequently than those without PCOS [11,12], and when they undergo ART treatment, they are more likely to have immature oocytes retrieved [13].”
BackgroundPolycystic ovary Syndrome in Adolescents: Pitfalls in Diagnosis and Management
Kostopoulou, E., Anagnostis, P. G., Bosdou, J. Κ., Spiliotis, B. E., & Goulis, D. G. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00388-9 · Cited by 30
Managing polycystic ovary syndrome in primary care
Lua, A., How, C. H., & King, T. (2018) · Singapore Medical Journal · doi:10.11622/smedj.2018135 · Cited by 33
Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone
Standeven, L. R., Olson, E. M., Leistikow, N., Payne, J. L., Osborne, L. M., & Hantsoo, L. V. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-021-01244-w · Cited by 24
Polycystic ovarian syndrome: A review covering phytoconstituents for its outstrip management
Joshi, M., Shankar, R., Pathak, K., & Yadav, R. (2021) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2021.100011 · Cited by 34
Fertility trends and comparisons in a historical cohort of US women with primary infertility
Sadecki, E. N., Weaver, A. L., Zhao, Y., Stewart, E. A., & Ainsworth, A. J. (2022) · Reproductive Health · doi:10.1186/s12978-021-01313-6 · Cited by 25
Pringle, D., Suliman, S., Seedat, S., & van den Heuvel, L. L. (2022) · Child Abuse & Neglect · doi:10.1016/j.chiabu.2022.105831 · Cited by 27
Suicide Attempts After a Diagnosis of Polycystic Ovary Syndrome: A Cohort Study
Hsu, T., Kao, Y., Tsai, S., Bai, Y., Su, T., Chen, T., Liang, C., & Chen, M. (2024) · Annals of Internal Medicine · doi:10.7326/m23-2240 · Cited by 29
Efficacy of Treatments for Polycystic Ovarian Syndrome Management in Adolescents
Khalifah, R. A. A., Flórez, I. D., Zoratti, M. J., Dennis, B. B., Thabane, L., & Bassilious, E. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa155 · Cited by 26
“PCOS increases risk of dysglycemia, hyperlipidemia, and obesity [6-18].”
BackgroundKumarendran, B., O’Reilly, M., Subramanian, A., Šumilo, D., Toulis, K. A., Gokhale, K. M., Wijeratne, C. N., Coomarasamy, A., Tahrani, A. A., Azoulay, L., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0437 · Cited by 26
ZareMobini, F., Kazemi, A., & Farajzadegan, Z. (2018) · Reproductive Health · doi:10.1186/s12978-018-0488-5 · Cited by 27
Medical Treatment and Comorbidity in Polycystic Ovary Syndrome: An Updated Review
Glintborg, D., & Andersen, M. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.02.014 · Cited by 20
Bariatric Surgery in Women with Polycystic Ovary Syndrome
Samarasinghe, S., Woods, C., & Miras, A. D. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155745 · Cited by 27
Associations Between Asthma and Polycystic Ovary Syndrome: Current Perspectives
Xu, Y., Zhou, Z., Pan, J., & Huang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.936948 · Cited by 20
“1%) and other gynecological diseases (13).”
BackgroundResultBarberis, N., Calaresi, D., Cannavò, M., & Verrastro, V. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.962083 · Cited by 23
“Weight management issues exacerbate the clinical significance of the disease, leading to important clinical concerns such as diabetes and cardiovascular disease (4, 5).”
BackgroundVilariño‐García, T., Pérez‐Pérez, A., Santamaría‐López, E., Prados, N., Sánchez, M. F., & Sánchez‐Margalet, V. (2020) · Endocrine Connections · doi:10.1530/ec-20-0062 · Cited by 18
Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome
Кялка, М., Milewicz, T., Sztefko, K., Rogatko, I., & Majewska, R. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s109086 · Cited by 18
Postnatal depression in a community‐based study of women with polycystic ovary syndrome
March, W. A., Whitrow, M. J., Davies, M. J., Fernandez, R. C., & Moore, V. (2018) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13332 · Cited by 18
“Impaired fertility means that women with PCOS are frequently clients of fertility clinics (5,10,11), a source of stress during treatment (12,13).”
BackgroundResultInfluentialTian, Y., Liu, Y., Wang, G., Lv, Y., Zhang, J., Bai, X., Zhang, H., & Song, X. (2020) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2020.101780 · Cited by 20
Maternal cholesterol levels during gestation: boon or bane for the offspring?
Jayalekshmi, V. S., & Ramachandran, S. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03916-2 · Cited by 21
Urbano, F., Chiarito, M., Lattanzio, C., Messa, A., Ferrante, M., Francavilla, M., Mehmeti, I., Lassandro, G., Giordano, P., & Faienza, M. F. (2022) · Children · doi:10.3390/children9111748 · Cited by 19
Coexistence of asthma and polycystic ovary syndrome: A concise review
Zierau, L., Gade, E. J., Lindenberg, S., Backer, V., & Thomsen, S. F. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.08.025 · Cited by 18
Mezzullo, M., Fanelli, F., Dalmazi, G. D., Fazzini, A., Gasparini, D. I., Mastroroberto, M., Guidi, J., Morselli‐Labate, A. M., Pasquali, R., Pagotto, U., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.02.022 · Cited by 18
Nasser, H. A., AbuelEzz, N. Z., Abdel-Mageed, H. M., & Radwan, R. A. (2019) · Journal of Medical Biochemistry · doi:10.2478/jomb-2019-0012 · Cited by 19
Ma, C., Peng, Q., Jiang, S., Chen, K., Fang, Y., & Zhang, J. (2018) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972018-00587 · Cited by 15
Anxiety, Depression, and Quality of Life After Procedural Intervention for Uterine Fibroids
Wallace, K. L., Stewart, E. A., Wise, L. A., Nicholson, W. K., Parry, J. P., Zhang, S., Laughlin-Tommaso, S. K., Jacoby, V. L., Anchan, R. M., Diamond, M. P., et al. (2021) · Journal of Women s Health · doi:10.1089/jwh.2020.8915 · Cited by 24
“32 The incidence of depression is higher among women with UFs who have hypertension, 11 which is consistent with our study findings.”
Sumathi, M., Chitra, P., Sheela, S., & Ishwarya, C. (2023) · The Imaging Science Journal · doi:10.1080/13682199.2023.2229016 · Cited by 21
“PCOS has serious medical repercussions for the health of women, hence resources for healthcare should be allocated accordingly [21].”
Davis, S., Hendryx, J., Menezes, C., Bouwer, S., Menezes, H., Patel, V., Bostick-Smith, C. A., & Speelman, D. L. (2020) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2020.051 · Cited by 19
Kangasniemi, M. H., Komsi, E. K., Rossi, H., Liakka, A., Khatun, M., Chen, J. C., Paulson, M., Hirschberg, A. L., Arffman, R. K., & Piltonen, T. (2022) · F&S Science · doi:10.1016/j.xfss.2022.01.006 · Cited by 24
Polycystic Ovary Syndrome (PCOS) and Non-Suicidal Self-Injury (NSSI): A Community-Based Study
Williams, S., Fido, D., & Sheffield, D. (2022) · Healthcare · doi:10.3390/healthcare10061118 · Cited by 17
“These findings support existing evidence from both quantitative and qualitative perspectives which report associations between PCOS and an increased risk of hospitalisation for self-harm (in addition to stress, anxiety, depression; [13]) and experiences of PCOS-driven suicidal ideation and engagement in self-harm”
BackgroundResultKim, J. H., Jung, M. H., Hong, S. H., Moon, N., & Kang, D. R. (2022) · Yonsei Medical Journal · doi:10.3349/ymj.2022.63.8.794 · Cited by 17
Malpique, R., Sánchez‐Infantes, D., García-Beltrán, C., Taxerås, S. D., López‐Bermejo, A., de Zegher, F., & Ibáñez, L. (2019) · Pediatric Obesity · doi:10.1111/ijpo.12500 · Cited by 15
“Polycystic ovary syndrome (PCOS) is a frequent cause of hirsutism and menstrual irregularity in adolescent girls and young women, is commonly accompanied by insulin resistance with compensatory hyperinsulinemia and hepato‐visceral fat excess, independently of BMI,(6) and is followed by comorbidities such as subfertili…”
BackgroundMidlife women’s health consequences associated with polycystic ovary syndrome
Ali, A. T., & Guidozzi, F. (2019) · Climacteric · doi:10.1080/13697137.2019.1679111 · Cited by 18
Li, J., Liu, X., Hu, L., Zhang, F., Wang, F., Kong, H., Dai, S., & Guo, Y. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00834 · Cited by 19
“Polycystic ovary syndrome (PCOS) is an endocrine disorder characterized by irregular menses, elevated androgen levels, hirsutism, insulin resistance, and polycystic ovaries, and it accounts for 18–25% of infertility among couples (1).”
BackgroundA Copeptin as a Predictor Marker for Insulin Resistance Among Women with Polycystic Ovary Syndrome
Ali, A. I., Nori, W., & Alrawi, S. (2021) · Current Women s Health Reviews · doi:10.2174/1573404817666211208152049 · Cited by 25
Shorakae, S., Lambert, É., Jona, E., Sari, C. I., de Courten, B. V., Dixon, J. B., Lambert, G. W., & Teede, H. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01486 · Cited by 17
Generational Health Impact of PCOS on Women and Their Children
Hart, R. J. (2019) · Medical Sciences · doi:10.3390/medsci7030049 · Cited by 26
“Taken at face value, this would appear hardly surprising in view of the increased health risks for the woman herself outside of pregnancy, with respect to cardiovascular and metabolic disorders [3,8] as pregnancy is a substantial cardiometabolic physiological challenge for any woman.”
BackgroundMethodSelf-citationMahboobifard, F., Rahmati, M., Niknam, A., Rojhani, E., Momenan, A. A., Azizi, F., & Tehrani, F. R. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2021.11.001 · Cited by 19
Kujanpää, L., Arffman, R. K., Pesonen, P., Hurskainen, E., Järvelin, M., Franks, S., Tapanainen, J. S., Morin-Papunen, L. C., & Piltonen, T. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae057 · Cited by 15
Khalifah, R. A. A., Flórez, I. D., Dennis, B. B., Neupane, B., Thabane, L., & Bassilious, E. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0105-4 · Cited by 15
“These patients are at increased risk of type 2 diabetes, hypertension, myocardial infarction, angina, and psychiatric diseases [21, 22] in addition to gynecological and obstetrical complications, such as infertility, higher rate for pregnancy loss, gestational diabetes, premature delivery, as well as gynecological and…”
BackgroundSpeelman, D. L. (2019) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2019.006 · Cited by 20
Grieger, J. A., Hodge, A. M., Mishra, G. D., Joham, A. E., & Moran, L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010233 · Cited by 14
Mechanisms of Scarless Repair at Time of Menstruation: Insights From Mouse Models
Kirkwood, P. M., Shaw, I., & Saunders, P. T. K. (2022) · Frontiers in Reproductive Health · doi:10.3389/frph.2021.801843 · Cited by 16
“These results may partially explain why women who have high androgen levels as a result of polycystic ovarian disease sometimes report heavy or extended bleeding during menses (45).”
BackgroundFemale-specific risk factors for cardiovascular disease: an update
Theodorou, A., Karagiannakis, D. S., Stefanaki, K., Kassi, E., Peppa, Μ., Vryonidou, A., & Paschou, S. Α. (2024) · HORMONES · doi:10.1007/s42000-024-00576-5 · Cited by 16
“In fact, on average, PCOS increases the risk of CVD by a factor of 1.5 to 2 compared to individuals without PCOS who are of the same age [60–63].”
InfluentialArora, S., Vedpal, & Chauhan, N. (2024) · Multimedia Tools and Applications · doi:10.1007/s11042-024-19707-6 · Cited by 20
“Hart et al. [59] have tried to find out how many women who had PCOS were admitted in hospitals as compared to those without PCOS.”
Guo, X., Yao, Y., Wang, T., Wu, J., & Jiang, R. (2024) · Hypertension in Pregnancy · doi:10.1080/10641955.2024.2379389 · Cited by 19
“In some cases, medications are required to induce ovulation in the presence of this metabolic condition (10,11).”
Kujanpää, L., Arffman, R. K., Vaaramo, E., Rossi, H., Laitinen, J. H., Morin-Papunen, L. C., Tapanainen, J. S., Ala‐Mursula, L., & Piltonen, T. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0027 · Cited by 20
Reproduction as a window to future health in women
Huttler, A., Murugappan, G., Stentz, N. C., & Cedars, M. I. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.01.005 · Cited by 16
Percy, C., Turner, A., & Orr, C. (2024) · JMIR Formative Research · doi:10.2196/52427 · Cited by 12
“PCOS has serious and complex long-term health consequences [19,20].”
BackgroundFaraj, R. M. L., Jawad, A. H., & Badr, A. H. (2019) · Journal of Al-Nahrain University-Science · doi:10.22401/anjs.22.1.06 · Cited by 10
“PCOS is not only a hyperandrogenic disorder associated with young and fertile-aged women but may have some health complications for the women in later life [9].”
BackgroundThe current landscape of mental health challenges in women with PCOS: a narrative review
Khan, F., Govender, N., & Thandar, Y. (2025) · Current Psychology · doi:10.1007/s12144-025-07435-5 · Cited by 17
“Several studies have demonstrated a strong association between PCOS and anxiety (Dokras et al., 2012; Hart & Doherty, 2015; Hu et al., 2024; Cooney et al., 2017).”
Polycystic Ovary Syndrome: A Brief Review with Recent Updates
Shermin, S., Noor, A., & Jahan, S. (2020) · Delta Medical College Journal · doi:10.3329/dmcj.v7i2.45567 · Cited by 22
The "asthma-polycystic ovary overlap syndrome" and the therapeutic role of myo-inositol
Guarnieri, G., Iervolino, M., Cavallone, S., Unfer, V., & Vianello, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086959 · Cited by 11
“Menstrual irregularities are one of the major clinical manifestations that affect women with PCOS, including irregular, anovulatory or absent cycles [25].”
BackgroundYe, Z., Zhao, J., & Li, R. (2022) · Gynecology and Obstetrics Clinical Medicine · doi:10.1016/j.gocm.2022.10.001 · Cited by 12
Zhang, M., Wang, Y. Y., Di, J., Zhang, X., Liu, Y., Zhang, Y., Li, B., Qi, S., Cao, X., Liu, L., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1414289 · Cited by 17
“Moreover, PCOS patients typically require a signi fi cantly highernumber of IVF treatment cycles compared to non-PCOS patients (4).”
BackgroundColombo, G. E., Mahamat‐Saleh, Y., Armour, M., Madan, K., Sabag, A., Kvaskoff, M., Missmer, S. A., Condous, G. S., Pathan, F. K., & Leonardi, M. (2025) · Heart · doi:10.1136/heartjnl-2024-324675 · Cited by 12
“…outcome of the association between NMGD and peripheral vascular disease was reported by five studies 17 24 26 28 42 ; however, only two studies 17 17 reported an effect estimate, calculating an HR of 1.81 (95% CI 1.59 to 2.05) for the association between peripheral vascular disease and PCOS.”
InfluentialChronotype and Sleep Quality Assessment of Patients with Polycystic Ovary Syndrome
Karasu, A. F. G., Şahbaz, Ç., DOĞU, Z. F. E., Takmaz, T., Öztürk, H. Ç., & Tanoğlu, F. B. (2021) · Medical Bulletin of Haseki · doi:10.4274/haseki.galenos.2021.6584 · Cited by 14
Lee, I. O., Kim, J. C., Seo, J. W., Pak, H. Y., & Chung, J. E. (2021) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2020.1849071 · Cited by 13
Nohr, E. A., Hansen, A. B., Andersen, M., & Hjorth, S. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13911 · Cited by 11
Metadata
- Authors
- Hart, R., & Doherty, D. A.
- Affiliations
- The University of Western Australia (AU)
- Corresponding author
- Hart, Roger
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-03
- Volume
- 100
- Issue
- 3
- Pages
- 911-919
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2098409670
- Cited by
- 391
- References
- 51
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 39 · 2023: 35 · 2022: 45 · 2021: 41 · 2020: 43 · 2019: 38 · 2018: 34 · 2017: 32 · 2016: 33 · 2015: 12
- FWCI
- 31.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, long-term health effects, hospitalization, type 2 diabetes, obesity, depression, anxiety, infertility, miscarriage, in vitro fertilization, menorrhagia, mortality, Western Australia, healthcare resource allocation, data linkage, women's health, vascular disease
- MeSH terms
- Adolescent, Adult, Australia, Data Collection, Female, Hospitalization, Humans, Middle Aged, Polycystic Ovary Syndrome, Pregnancy, Time Factors, Comorbidity, Case-Control Studies, Young Adult, Reproductive Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.